HuGE Literature Finder
Records 1-30
Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer.
Scientific reports 2021 Jan 11 (1): 441. Nakamura Yuki, Yokoyama Shozo, Matsuda Kenji, Tamura Koichi, Mitani Yasuyuki, Iwamoto Hiromitsu, Mizumoto Yuki, Murakami Daisuke, Kitahata Yuji, Yamaue Hiro |
Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients-The Importance of Tissue/Plasma Discordant Cases.
Journal of clinical medicine 2020 Dec 10 (1): . Formica Vincenzo, Lucchetti Jessica, Doldo Elena, Riondino Silvia, Morelli Cristina, Argirò Renato, Renzi Nicola, Nitti Daniele, Nardecchia Antonella, Dell'Aquila Emanuela, Ferroni Patrizia, Guadagni Fiorella, Palmieri Giampiero, Orlandi Augusto, Roselli Mar |
CT Texture Analysis: A Potential Biomarker for Evaluating KRAS Mutational Status in Colorectal Cancer.
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 2020 Dec 35 (4): 306-314. Cao Jian, Wang Guo Rong, Wang Zhi Wei, Jin Zheng |
Impact and clinical usefulness of genetic data in the surgical management of colorectal cancer liver metastasis: a narrative review.
Hepatobiliary surgery and nutrition 2020 Dec 9 (6): 705-716. Margonis Georgios Antonios, Kreis Martin E, Wang Jaeyun Jane, Kamphues Carsten, Wolfgang Christopher L, Weiss Matthew |
MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway.
Clinical colorectal cancer 2020 Dec . Chuang Jeremy, Wang Chongkai, Guo Yuming, Valenzuela Valerie, Wu Jun, Fakih Marw |
Results of in vitro test-KRAStissue reagent kit test to determine indications for target therapy of patients diagnosed with colorectal cancer.
Klinicheskaia laboratornaia diagnostika 2020 Dec 65 (12): 793-800. Toropovskiy A N, Pavlova Olga Nikolaevna, Viktorov D A, Nikitin A G, Maslyakov V |
The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status.
Journal of surgical oncology 2020 Dec . Kamphues Carsten, Kadowaki Shigenori, Amini Neda, van den Berg Inge, Wang Jaeyun, Andreatos Nikolaos, Sakamoto Yuki, Ogura Toshiro, Kakuta Miho, Pikouli Anastasia, Geka Despoina, Daitoku Nobuya, Theochari Maria, Buettner Stefan, Akiyama Takahiko, Antoniou Efstathios, Pikoulis Emmanouil, Theodoropoulos George, Imai Katsunori, Ijzermans Jan N M, Margonis Georgios A, Akagi Kiwamu, Kreis Martin |
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial.
Clinical chemistry 2020 Nov . Lueong Smiths S, Herbst Andreas, Liffers Sven-Thorsten, Bielefeld Nicola, Horn Peter A, Tannapfel Andrea, Reinacher-Schick Anke, Hinke Axel, Hegewisch-Becker Susanna, Kolligs Frank T, Siveke Jens |
The value of haematological parameters and serum tumour markers for predicting KRAS mutations in 784 Chinese colorectal cancer patients: a retrospective analysis.
BMC cancer 2020 Nov 20 (1): 1099. Cao Yinghao, Gu Junnan, Yan Lizhao, Deng Shenghe, Mao Fuwei, Cai Wentai, Li Hang, Liu Xinghua, Wang Jiliang, Wu Ke, Cai Kail |
Wild-type APC is associated with poor survival in metastatic microsatellite stable colorectal cancer.
The oncologist 2020 Nov . Wang Chongkai, Ouyang Ching, Cho May, Ji Jingran, Sandhu Jaideep, Goel Ajay, Kahn Michael, Fakih Marw |
Characterization of genomic alterations in Chinese colorectal cancer patients.
Japanese journal of clinical oncology 2020 Oct . Huang Wei, Li Hui, Shi Xiaoliang, Lin Minglin, Liao Cun, Zhang Shuirong, Shi Weiwei, Zhang Lin, Zhang Xiaolong, Gan Jialia |
Expanded low allele frequency RAS and BRAF V600E testing in metastatic colorectal cancer as predictive biomarkers for cetuximab in the randomized CO.17 trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Oct . Loree Jonathan M, Dowers Anthony, Tu Dongsheng, Jonker Derek, Edelstein Daniel L, Quinn Hannah, Holtrup Frank, Price Timothy, Zalcberg John R, Moore Malcolm J, Karapetis Christos S, O'Callaghan Chris J, Waring Paul, Kennecke Hagen F, Hamilton Stanley R, Kopetz Sco |
Frequency and Coexistence of KRAS, NRAS, BRAF, and PIK3CA Mutations and occurrence of MMR deficiency in Danish Colorectal Cancer Patients.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2020 Oct . Poulsen Tim Svenstrup, de Oliveira Douglas Vinicius Nogueira Perez, Espersen Maiken Lise Marcker, Klarskov Louise Laurberg, Skovrider-Ruminski Wojciech, Hogdall Estr |
Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
Inflammatory bowel diseases 2020 Oct . Matsumoto Kenta, Urabe Yuji, Oka Shiro, Inagaki Katsuaki, Tanaka Hidenori, Yuge Ryo, Hayashi Ryohei, Kitadai Yasuhiko, Arihiro Koji, Shimamoto Fumio, Tanaka Shinji, Chayama Kazua |
Serrated Lesions in Inflammatory Bowel Disease: Genotype-Phenotype Correlation.
International journal of surgical pathology 2020 Oct 1066896920963798. Brcic Iva, Dawson Heather, Gröchenig Hans Peter, Högenauer Christoph, Kashofer Ka |
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy (RELAIS) translational biomarker phase II pilot study.
International journal of cancer 2020 Sep . Unseld Matthias, Belic Jelena, Pierer Kerstin, Zhou Qing, Moser Tina, Bauer Raimund, Piringer Gudrun, Gerger Armin, Siebenhüner Alexander, Speicher Michael, Heitzer Ellen, Prager Gerald |
Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancer.
Turkish journal of medical sciences 2020 Sep . Ounissi Donia, Weslati Marwa, Boughriba Rahma, Hazgui Meriam, Bouraoui Saad |
KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report.
Translational oncology 2020 Sep 13 (12): 100874. Luo Qianxin, Chen Dianke, Fan Xinjuan, Fu Xinhui, Ma Tenghui, Chen Dai |
ASO Author Reflections: Poorest Survival Outcomes in Patients with Right Colon Cancer with KRAS Mutation After Simultaneous Curative-Intent Surgery for Colorectal Cancer Liver Metastases.
Annals of surgical oncology 2020 Aug . Kim Ho Seung, Kim Nam K |
Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST).
European journal of cancer (Oxford, England : 1990) 2020 Aug 138 19-29. Tsai Hsiang-Lin, Huang Ching-Wen, Lin Yi-Wen, Wang Jui-Ho, Wu Chang-Chieh, Sung Yung-Chuan, Chen Tzu-Liang, Wang Hwei-Ming, Tang Hsiu-Chin, Chen Joe-Bin, Ke Tao-Wei, Tsai Chang-Sung, Huang Hsuan-Yuan, Wang Jaw-Yu |
Intake of dietary fruit, vegetables, and fiber and risk of colorectal cancer according to molecular subtypes: A pooled analysis of 9 studies.
Cancer research 2020 Aug . Hidaka Akihisa, Harrison Tabitha A, Cao Yin, Sakoda Lori C, Barfield Richard, Giannakis Marios, Song Mingyang, Phipps Amanda I, Figueiredo Jane C, Zaidi Syed H, Toland Amanda E, Amitay Efrat L, Berndt Sonja I, Borozan Ivan, Chan Andrew T, Gallinger Steven, Gunter Marc J, Guinter Mark A, Harlid Sophia, Hampel Heather, Jenkins Mark A, Lin Yi, Moreno Victor, Newcomb Polly A, Nishihara Reiko, Ogino Shuji, Obón-Santacana Mireia, Parfrey Patrick S, Potter John D, Slattery Martha L, Steinfelder Robert S, Um Caroline Y, Wang Xiaoliang, Woods Michael O, Van Guelpen Bethany, Thibodeau Stephen N, Hoffmeister Michael, Sun Wei, Hsu Li, Buchanan Daniel D, Campbell Peter T, Peters Ulri |
Prognosis of Synchronous Colorectal Liver Metastases After Simultaneous Curative-Intent Surgery According to Primary Tumor Location and KRAS Mutational Status.
Annals of surgical oncology 2020 Aug . Kim Ho Seung, Lee Jong Min, Kim Han Sang, Yang Seung Yoon, Han Yoon Dae, Cho Min Soo, Hur Hyuk, Min Byung Soh, Lee Kang Young, Kim Nam K |
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
European journal of cancer (Oxford, England : 1990) 2020 Aug 137 250-259. Stahler Arndt, Stintzing Sebastian, von Einem Jobst C, Westphalen Christoph B, Heinrich Kathrin, Krämer Nicole, Michl Marlies, Modest Dominik P, von Weikersthal Ludwig Fischer, Decker Thomas, Kiani Alexander, Heintges Tobias, Kahl Christoph, Kullmann Frank, Scheithauer Werner, Moehler Markus, Kaiser Florian, Kirchner Thomas, Jung Andreas, Heinemann Volk |
Cancer-Associated Mutations in Normal Colorectal Mucosa Adjacent to Sporadic Neoplasia.
Clinical and translational gastroenterology 2020 Jul 11 (7): e00212. Zhan Tianzuo, Belle Sebastian, Valentini Erica, Herrmann Simon, Miersch Thilo, Li Moying, Gaiser Timo, Boutros Michael, Ebert Matthias P, Betge Johann |
Complete Screening of Exons 2, 3, and 4 of KRAS and NRAS Genes Reveals a Higher Number of Clinically Relevant Mutations than Food and Drug Administration Quantitative Polymerase Chain Reaction-Based Commercial Kits.
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 2020 May 73 (3): . Sánchez-Ibarra Héctor E, Reyes-Cortes Luisa M, López-Tavera Esteban, Luna-Aguirre Claudia M, Barrera-Saldaña Hugo |
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial.
Clinical colorectal cancer 2020 Mar . Kasper Stefan, Meiler Johannes, Knipp Heike, Höhler Thomas, Reimer Peter, Steinmetz Tilman, Berger Winfried, Linden Gabriele, Reis Henning, Markus Peter, Paul Andreas, Dechêne Alexander, Schumacher Brigitte, Kostbade Karina, Virchow Isabel, Ting Saskia, Worm Karl, Schmid Kurt W, Herold Thomas, Wiesweg Marcel, Schuler Martin, Trarbach Tan |
Clinical features and KRAS mutation in colorectal cancer with bone metastasis.
Scientific reports 2020 12 10 (1): 21180. Park Hyung Soon, Chun You Jin, Kim Han Sang, Kim Jee Hung, Lee Choong-Kun, Beom Seung-Hoon, Shin Sang Joon, Ahn Joong B |
Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer.
Frontiers in oncology 2020 10 568911. Xu Ting, Zhang Yinjie, Zhang Jing, Qi Changsong, Liu Dan, Wang Zhenghang, Li Yanyan, Ji Congcong, Li Jian, Lin Xuan, Hou Ting, Liu Hao, Zhang Lu, Han-Zhang Han, Shen Lin, Wang Xiche |
IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER.
Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery 2020 33 (3): e1524. Zanatto Renato Morato, Santos Gianni, Oliveira Júnea Caris, Pracucho Eduardo Marcucci, Nunes Adauto José Ferreira, Lopes-Filho Gaspar Jesus, Saad Sarhan Sydn |
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research.
OncoTargets and therapy 2020 13 12601-12613. He Kang, Wang Yajing, Zhong Yuejiao, Pan Xiaohua, Si Lixiang, Lu Jianw |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: